Traws Pharma, Inc. (TRAW) — Analyst outlook / Analyst consensus target is.
The consensus price target is $8.00, representing an upside of 550.4% from the current price $1.23.
Analysts estimate Earnings Per Share (EPS) of $-154.35 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-6.58 vs est $-154.35 (beat +95.7%). Analyst accuracy: 0%.
TRAW Stock — 12-Month Price Forecast
$8.00
▲ +550.41% Upside
Average Price Target
Based on 0 Wall Street analysts offering 12-month price targets for Traws Pharma, Inc., the price target is $8.00.
The average price target represents a +550.41% change from the last price of $1.23.
EPS Estimates — TRAW
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual –$6.58
vs Est –$154.35
▲ 2,245.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — TRAW
98%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▼ 1.8% off
Revenue Trend
Analysts expect stable revenue going forward.
